Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anglin

Showing results (421-430 of 910) with videos related to

Pageof 91
Sort By:
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|March 1, 1973
Identification of the quality and quantity of (biologically significant) cotton mill dustD P Anderson, M C Anglin, H E Ayer, et al.
Psychiatry Research|December 8, 2025
Reasons for discrimination and mental health symptoms among ethnoracially diverse individuals in the early stages of psychosisMegan Puzia, Bryony Stokes, Hans Y Oh, et al.
Pharmacy Practice|January 14, 2016
The prevalence of major potential drug-drug interactions at a University health centre pharmacy in JamaicaTracia-Gay Kennedy-Dixon, Maxine Gossell-Williams, Jannel Hall, et al.
Maternal and Child Health Journal|November 10, 2017
After The Demonstration: What States Sustained After the End of Federal Grants to Improve Children's Health Care QualityHenry T Ireys, Cindy Brach, Grace Anglin, et al.
Springerplus|May 29, 2015
The impact of use of an intraoperative margin assessment device on re-excision ratesMolly Sebastian, Stephanie Akbari, Beth Anglin, et al.
Diabetes Care|November 28, 2002
Effects of tadalafil on erectile dysfunction in men with diabetesIñigo Sáenz de Tejada, Greg Anglin, James R Knight, et al.
Substance Use & Misuse|January 5, 2002
Comment on "nonresponse and selection bias in treatment follow-up studies"P M Flynn, D D Simpson, M D Anglin, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 26, 2001
Pharmacokinetics of midazolam in critically ill pediatric patientsM C Nahara, J McMorrow, P R Jones, et al.
JAMA|July 1, 1974
Recurrent meningococcal infection with an antigenically identical strainJ M Griffiss, R M Bannatyne, M S Artenstein, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Implementation of Structured Benefit-Risk Assessments in Marketing Authorization Applications: Lessons LearnedJuAn Wang, Anne Wolka, Kristin Bullok, et al.
Pageof 91

Showing results (421-430 of 910) with videos related to

Sort By:
Pageof 91
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|March 1, 1973
Identification of the quality and quantity of (biologically significant) cotton mill dustD P Anderson, M C Anglin, H E Ayer, et al.
Psychiatry Research|December 8, 2025
Reasons for discrimination and mental health symptoms among ethnoracially diverse individuals in the early stages of psychosisMegan Puzia, Bryony Stokes, Hans Y Oh, et al.
Pharmacy Practice|January 14, 2016
The prevalence of major potential drug-drug interactions at a University health centre pharmacy in JamaicaTracia-Gay Kennedy-Dixon, Maxine Gossell-Williams, Jannel Hall, et al.
Maternal and Child Health Journal|November 10, 2017
After The Demonstration: What States Sustained After the End of Federal Grants to Improve Children's Health Care QualityHenry T Ireys, Cindy Brach, Grace Anglin, et al.
Springerplus|May 29, 2015
The impact of use of an intraoperative margin assessment device on re-excision ratesMolly Sebastian, Stephanie Akbari, Beth Anglin, et al.
Diabetes Care|November 28, 2002
Effects of tadalafil on erectile dysfunction in men with diabetesIñigo Sáenz de Tejada, Greg Anglin, James R Knight, et al.
Substance Use & Misuse|January 5, 2002
Comment on "nonresponse and selection bias in treatment follow-up studies"P M Flynn, D D Simpson, M D Anglin, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 26, 2001
Pharmacokinetics of midazolam in critically ill pediatric patientsM C Nahara, J McMorrow, P R Jones, et al.
JAMA|July 1, 1974
Recurrent meningococcal infection with an antigenically identical strainJ M Griffiss, R M Bannatyne, M S Artenstein, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Implementation of Structured Benefit-Risk Assessments in Marketing Authorization Applications: Lessons LearnedJuAn Wang, Anne Wolka, Kristin Bullok, et al.
Pageof 91